| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/23/2002 | WO2002040002A2 Method for modulation, stimulation, and inhibition of glutamate reuptake |
| 05/23/2002 | WO2002039998A2 Methods and compositions for regulating memory consolidation |
| 05/23/2002 | WO2002039991A2 Prevention of development of dyskinesias |
| 05/23/2002 | WO2002039989A1 Novel use of combined 5-ht1a agonists and selective serotonin reuptake inhibitors |
| 05/23/2002 | WO2002039988A2 Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht1a receptor agonists |
| 05/23/2002 | WO2002039879A2 Treatment of anti-depression drug-induced sexual dysfunction with apomorphine |
| 05/23/2002 | WO2002034267A8 Combination of a transdermal therapeutic system and an oral and/or parenteral preparation containing dopamine agonists for the treatment of dopaminergic disease states |
| 05/23/2002 | WO2002015903A3 Novel pharmaceutical composition for administering n-0923 |
| 05/23/2002 | WO2002014313A3 Novel beta-amyloid inhibitors, method for producing the same and the use thereof as medicaments |
| 05/23/2002 | WO2002006213A3 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
| 05/23/2002 | WO2002003911B1 Prevention and treatment of alzheimer's disease |
| 05/23/2002 | WO2002000638A3 Substituted phthalides as anti-convulsive drugs |
| 05/23/2002 | WO2001096603A3 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions |
| 05/23/2002 | WO2001094306A3 (bis)sulfonamide derivatives |
| 05/23/2002 | WO2001092253A3 Inhibitors of alpha l beta 2 mediated cell adhesion |
| 05/23/2002 | WO2001091720A3 Preparation of injectable suspensions having improved injectability |
| 05/23/2002 | WO2001090182A3 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits |
| 05/23/2002 | WO2001087884A3 Polyketide derivatives |
| 05/23/2002 | WO2001087284A3 Aldosterone antagonist composition for release during aldosterone acrophase |
| 05/23/2002 | WO2001083715A3 Derivation of midbrain dopaminergic neurons from embryonic stem cells |
| 05/23/2002 | WO2001080845A3 (2-aminoethyl) oxime derivatives for the treatment of depression |
| 05/23/2002 | WO2001079444A3 Albumin fusion proteins |
| 05/23/2002 | WO2001079164A3 N-substituted dithiocarbamates for the treatment of biological disorders |
| 05/23/2002 | WO2001078753A3 Therapeutic uses for mesenchymal stromal cells |
| 05/23/2002 | WO2001077687A3 Prion-binding peptidic ligands and methods of using same |
| 05/23/2002 | WO2001074344A3 Small organic molecule regulators of cell proliferation |
| 05/23/2002 | WO2001072707A3 Carbamate caspase inhibitors and uses thereof |
| 05/23/2002 | WO2001064837A8 β NETRIN AND USES THEREOF |
| 05/23/2002 | WO2001063295A3 Dpi-6, a therapeutic biomarker in neurological disorders |
| 05/23/2002 | WO2001053506A3 Virus strains for the oncolytic treatment of cancer |
| 05/23/2002 | WO2001049651A3 Aminomethyl-phenyl-cyclohexanone derivatives |
| 05/23/2002 | WO2001047946A9 GFRα1-RET SPECIFIC AGONISTS AND METHODS THEREFOR |
| 05/23/2002 | WO2001044206A9 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 05/23/2002 | WO2001041760A9 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 05/23/2002 | WO2001030330A3 Method to treat pain utilizing benzimidazole nmda/nr2b antagonists |
| 05/23/2002 | WO2001022953A3 Use of retigabin for treating neuropathic pain |
| 05/23/2002 | WO2000063204A3 Substituted azoles |
| 05/23/2002 | WO2000054765A8 Method of treating eating disorders |
| 05/23/2002 | US20020062022 Processes for preparation of cyclopenta [b] [1,4] diazepino [6,7,1-hi] indoles and derivatives |
| 05/23/2002 | US20020062008 Novel human beta2 integrin alpha subunit |
| 05/23/2002 | US20020061920 Selected fused pyrrolocarbazoles |
| 05/23/2002 | US20020061914 Benzothiazole, benzooxazole and benzoimidazole derivatives as sodium or calcium channel modulators |
| 05/23/2002 | US20020061912 Piperidinylmethyloxazolidinone derivative |
| 05/23/2002 | US20020061910 Optically pure reboxetine or its methanesulfonate salt inhibits reuptake of norepinephrine |
| 05/23/2002 | US20020061905 Ethers of 7-desmethylrapamycin |
| 05/23/2002 | US20020061904 Hydroxyesters of 7-desmethylrapamycin |
| 05/23/2002 | US20020061891 Indole derivatives as 5-HT1B and 5-HT1D agonists |
| 05/23/2002 | US20020061887 For therapy and prophylaxis of cardiovascular diseases such as hypertension, angina pectoris, cardiac insufficiency, thromboses or atherosclerosis |
| 05/23/2002 | US20020061886 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof |
| 05/23/2002 | US20020061881 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
| 05/23/2002 | US20020061874 Substituted lactam; gamma-secretase inhibitor; decreases production of beta-amyloid; treatment for Altzheimer's and Down's syndrome |
| 05/23/2002 | US20020061873 Having high bioavailability levels and reduced variability of bioavailability by use of dispersed, colloidal structures, colloids or analogous structures of the drug, a hydrophilic component, and a surfactant |
| 05/23/2002 | US20020061853 Caspase inhibtors and uses thereof |
| 05/23/2002 | US20020061846 Administering to a mammal Group B- beta hemolytic streptococci(GBS) toxin receptors or immunogenic fragments to induce an immune response to the GBS receptors for prventing pathoangiogenic conditions |
| 05/23/2002 | US20020061840 Tripeptide compounds useful as selective inhibitors of aminopeptidase A and corresponding pharmaceutical compositions |
| 05/23/2002 | US20020061834 Human G-protein Chemokine receptor (CCR5) HDGNR10 |
| 05/23/2002 | US20020061553 Partners of the PTB1 domain of FE65, preparation and uses |
| 05/23/2002 | US20020061339 Compositions and methods for use of extracts of rutaceae plants |
| 05/23/2002 | US20020059939 Device and method for the cessation of smoking |
| 05/23/2002 | DE10058119A1 Pharmaceutical kit containing repinotan, for use in acute treatment of neurological disorders such as stroke, including assay composition for determining body repinotan levels to optimize dosage |
| 05/23/2002 | DE10057754A1 New cyclic sulfonamido-substituted pyrazolo (3,4-b) pyridine derivatives, are soluble guanylate cyclase stimulants useful e.g. for treating cardiovascular or central nervous system diseases, sexual dysfunction or inflammation |
| 05/23/2002 | DE10057751A1 New carbamate-substituted pyrazolo (3,4-b) pyridine derivatives, are soluble guanylate cyclase stimulants useful e.g. for treating cardiovascular or central nervous system diseases, sexual dysfunction or inflammation |
| 05/23/2002 | CA2632696A1 Modified clostridial neurotoxins with altered biological persistence |
| 05/23/2002 | CA2460057A1 Protein prenyl transferase inhibitors in the treatment of neuroinflammatory disease |
| 05/23/2002 | CA2448729A1 Piperazinyl and piperidyl substituted heterocyclic compounds |
| 05/23/2002 | CA2429897A1 M. tuberculosis chaperonin 10 and uses thereof |
| 05/23/2002 | CA2429894A1 M. tuberculosis chaperonin 60.1 and uses thereof |
| 05/23/2002 | CA2429628A1 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors |
| 05/23/2002 | CA2429455A1 Fat regulated genes, uses thereof, and compounds for modulating same |
| 05/23/2002 | CA2429329A1 Bombesin receptor antagonists |
| 05/23/2002 | CA2429195A1 Immunoglobulin superfamily proteins |
| 05/23/2002 | CA2429180A1 Discordant helix stabilization for prevention of amyloid formation |
| 05/23/2002 | CA2429047A1 Treatment of anti-depression drug-induced sexual dysfunction with apomorphine |
| 05/23/2002 | CA2428863A1 Cysteine protease inhibitors |
| 05/23/2002 | CA2428844A1 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
| 05/23/2002 | CA2428787A1 Benzimidazole derivatives |
| 05/23/2002 | CA2428754A1 Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
| 05/23/2002 | CA2428709A1 Association of calpain inhibitors and reactive oxygen species trapping agents |
| 05/23/2002 | CA2428527A1 (dihydro)isoquinoline derivatives as phosphodiesterase inhibitors |
| 05/23/2002 | CA2428519A1 Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht1a receptor agonists |
| 05/23/2002 | CA2428350A1 Slo2 and slo4, novel potassium channel proteins from human brain |
| 05/23/2002 | CA2428136A1 Modified clostridial neurotoxins with altered biological persistence |
| 05/23/2002 | CA2427900A1 Substituted 2-phenylaminoimidazoline phenyl ketone derivatives as ip antagonists |
| 05/23/2002 | CA2427896A1 Carrier vectors through an epithelium with tight junctions |
| 05/23/2002 | CA2427819A1 Method for modulation, stimulation, and inhibition of glutamate reuptake |
| 05/23/2002 | CA2427656A1 Crf receptor antagonists and methods relating thereto |
| 05/23/2002 | CA2427296A1 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders |
| 05/23/2002 | CA2426089A1 Bombesin receptor antagonists |
| 05/23/2002 | CA2426069A1 Treatment of anxiety disorders |
| 05/22/2002 | EP1207200A1 High affinity choline transporter |
| 05/22/2002 | EP1207159A1 Aromaheterocyclic derivatives as dopamine D4 receptor antagonists |
| 05/22/2002 | EP1206934A1 Blockade of sodium channels by phenol derivatives |
| 05/22/2002 | EP1206578A2 Bdnf polymorphism and association with bipolar disorder |
| 05/22/2002 | EP1206562A2 Genetically engineered cell lines, and their uses, in particular for neurotoxicity testing |
| 05/22/2002 | EP1206554A1 Activatable recombinant neurotoxins |
| 05/22/2002 | EP1206553A2 Isomerase proteins |
| 05/22/2002 | EP1206543A2 Membrane associated proteins |
| 05/22/2002 | EP1206541A1 Dendritic enriched secreted lymphocyte activation molecule |
| 05/22/2002 | EP1206491A1 Tgf-beta receptor polynucleotides, polypeptides, and antibodies |
| 05/22/2002 | EP1206489A2 Orally active peptides that prevent cell damage and death |